KATHLEEN BOUDREAUX: Open Payments
NPI 1659540250 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 29 payments from 7 companies in 2025. Trend: 2023 $237 · 2024 $584 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $193 |
| Neurocrine BioSciences, Inc. | 2 | $108 |
| Corium, LLC | 5 | $69 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, INGREZZA, Azstarys, REXULTI, RELISTOR, Qelbree.
Industry payments across LA — which companies pay providers there.
